The Biological Diversity Act, 2002 addressed a specific concern distinct from habitat and species protection alone: unauthorised access to India's rich biological resources and associated traditional knowledge by external parties, extracting economic value without benefit flowing back to India or the communities whose traditional knowledge contributed to that value.
Legal Framework
| Provision | Content |
|---|---|
| S.3 | Requires prior approval of the National Biodiversity Authority before certain persons access biological resources for research or commercial use |
| S.19 | Requires approval before obtaining intellectual property rights based on research involving Indian biological resources |
| S.21 | Requires equitable benefit-sharing arrangements |
| Institutional structure | National Biodiversity Authority, State Biodiversity Boards, Biodiversity Management Committees |
Why the Act Addressed Biopiracy as a Distinct Concern
Prior to this Act, instances arose where foreign entities accessed India's biological resources (plants, genetic material) and associated traditional knowledge (regarding medicinal or other beneficial properties of specific plants, developed and maintained over generations by local and indigenous communities), subsequently obtaining patents or other intellectual property protection based on this access, without providing any compensation, recognition, or benefit-sharing back to India or the specific communities whose traditional knowledge had substantially contributed to identifying or developing the relevant biological resource's valuable properties.
Why this specific pattern, often termed biopiracy, warranted dedicated legislative attention: This pattern represented a form of value extraction where genuine economic value, substantially derived from India's biological resources and associated traditional community knowledge, was being captured entirely by external parties through intellectual property mechanisms, without any corresponding benefit flowing back to the resource's country of origin or the communities whose accumulated traditional knowledge had often been essential to identifying the resource's specific valuable properties in the first place; the Act was specifically designed to prevent this uncompensated value extraction, ensuring access to Indian biological resources occurs through a regulated process that includes appropriate benefit-sharing arrangements.
The Prior Approval Mechanism
Section 3 requires specified categories of persons (particularly foreign nationals, foreign companies, and non-resident Indians) to obtain prior approval from the National Biodiversity Authority before accessing Indian biological resources for research or commercial utilisation, or before transferring the results of such research to any such foreign person or entity.
Why this approval requirement is specifically calibrated to distinguish foreign and domestic access: The specific biopiracy concern the Act addresses primarily involves external parties extracting value from Indian resources without benefit flowing back to India; calibrating the approval requirement specifically to foreign access (while generally treating Indian citizens and entities somewhat differently, often subject to a notification rather than full approval requirement, reflecting the different underlying concern applicable to domestic use) targets the mechanism specifically at the biopiracy pattern of concern, without imposing the same restrictive approval burden on domestic research and use that does not present this same specific external value-extraction concern.
Approval Before Intellectual Property Rights
Section 19 requires approval from the National Biodiversity Authority before any person seeks intellectual property rights, whether in India or abroad, based on research or information relating to Indian biological resources.
Why this specific provision targets the intellectual property application stage directly: Since biopiracy's ultimate harm typically crystallises at the point where external parties secure exclusive intellectual property rights over resources or knowledge substantially derived from India, without corresponding benefit-sharing, requiring prior approval specifically before this intellectual property application stage provides a critical checkpoint precisely at the moment this potential harm would otherwise be finally locked in through legal protection, allowing the Authority to review and potentially require appropriate benefit-sharing arrangements before, rather than after, this intellectual property protection is secured.
Equitable Benefit-Sharing
Section 21 requires the National Biodiversity Authority, when granting approvals under the Act, to ensure equitable sharing of benefits arising from the use of accessed biological resources, knowledge, or associated traditional knowledge, with the benefit-sharing arrangement determined based on mutually agreed terms between the person seeking approval and the Authority (which represents the broader national and community interest in this context), potentially including monetary compensation, joint ownership of resulting intellectual property, or other benefit-sharing arrangements as appropriate to the specific circumstances.
Why mandatory benefit-sharing constitutes this Act's core substantive remedy against biopiracy, beyond merely the procedural approval requirement itself: The approval requirement alone, without a substantive benefit-sharing obligation attached, would merely require foreign parties to seek permission before accessing Indian resources, without necessarily ensuring any actual compensation or benefit flows back to India or affected communities; the mandatory benefit-sharing requirement ensures the Act's core underlying concern, preventing uncompensated value extraction, is substantively addressed through this specific compensatory mechanism, not merely through a procedural approval gate that could otherwise be satisfied without any genuine benefit actually returning to the resource's country and community of origin.
Illustrations
-
Prior approval, foreign research access: A foreign pharmaceutical research company wishes to study a specific plant species native to India, believed to possess medicinal properties potentially useful for drug development, requiring access to samples of this plant and consultation regarding traditional knowledge a specific local community holds regarding its use. Applying Section 3, this company must obtain prior approval from the National Biodiversity Authority before accessing this resource and associated knowledge for this research purpose.
-
Section 19 checkpoint, intellectual property application: Following successful research, the same foreign company wishes to apply for a patent based on findings substantially derived from this Indian plant species and the associated traditional knowledge. Applying Section 19, the company must obtain prior Authority approval before proceeding with this patent application, providing the critical checkpoint before this intellectual property protection, potentially locking in uncompensated value extraction, is actually secured.
-
Equitable benefit-sharing arrangement: As part of granting approval for the research and subsequent patent application, the National Biodiversity Authority, applying Section 21, negotiates and establishes a benefit-sharing arrangement requiring the foreign company to provide specific monetary compensation and to share a portion of any resulting commercial revenue with the specific local community whose traditional knowledge substantially contributed to identifying this plant's valuable properties, ensuring the community and India's broader interest receive genuine, substantive benefit from this research and commercialisation, rather than the value being captured entirely by the foreign company alone.
Recall Check
- Why did the pattern of biopiracy warrant this Act's dedicated legislative attention, distinct from habitat and species protection concerns?
- Why does the Section 3 approval requirement specifically calibrate to foreign, rather than uniformly to all, access to Indian biological resources?
- Why does mandatory benefit-sharing under Section 21 constitute the Act's core substantive remedy, beyond the procedural approval requirement alone?
Distinctions
| Basis | Section 3 (Access Approval) | Section 19 (IP Rights Approval) |
|---|---|---|
| Trigger point | Initial access to biological resources for research or commercial use | Subsequent application for intellectual property rights based on that research |
| Function | Regulates the access itself | Regulates the point where value extraction risks being legally locked in |
Flashcards
Q: What specific pattern of concern did the Biological Diversity Act, 2002 primarily address? A: Biopiracy: unauthorised extraction of value from Indian biological resources and traditional knowledge without benefit flowing back to India or affected communities.
Q: What does Section 3 require before certain persons access Indian biological resources? A: Prior approval from the National Biodiversity Authority.
Q: What does Section 19 specifically require approval for? A: Seeking intellectual property rights based on research involving Indian biological resources.
Q: What does Section 21 require the National Biodiversity Authority to ensure? A: Equitable sharing of benefits arising from use of accessed biological resources and associated traditional knowledge.
Q: Why is mandatory benefit-sharing considered the Act's core substantive remedy? A: It ensures actual, substantive compensation flows back to India and affected communities, rather than merely requiring procedural approval without any genuine benefit-sharing consequence.
Exam Scenario
A foreign cosmetics company, having obtained samples of a specific Indian plant through what it claims was a legitimate commercial purchase from a local vendor, conducts research revealing valuable skincare properties substantially informed by traditional knowledge a specific indigenous community had developed and used for generations, and proceeds to file a patent application in its home country based on these findings, without having sought any approval from India's National Biodiversity Authority at any stage. Assess the Act's application to this scenario.
Approach: Apply Section 3, confirming that regardless of the company's claimed legitimate commercial purchase of the physical plant samples, its subsequent research utilising this Indian biological resource for commercial purposes required prior National Biodiversity Authority approval, which the company appears not to have sought, constituting a likely violation of this access approval requirement. Apply Section 19 as an additional, independent violation, confirming that filing a patent application based on this research, without having obtained the required prior approval before this intellectual property application stage, constitutes a further violation of this specific checkpoint requirement. Advise that India would have grounds to challenge this patent application, and potentially pursue enforcement action against the company for failing to comply with either the access approval or the intellectual property approval requirements, and that any legitimate patent protection would, in any event, require the company to first satisfy the equitable benefit-sharing arrangement Section 21 mandates, specifically compensating the indigenous community whose traditional knowledge substantially contributed to this discovery, none of which appears to have occurred in this scenario, illustrating precisely the biopiracy pattern this Act was designed to prevent.
See Also
- Wildlife Protection Act 1972 : the related species-focused conservation framework, distinct from this file's specific concern with biological resource access and traditional knowledge protection, though both contribute to India's broader biodiversity conservation legal architecture.